Status:
UNKNOWN
Melatonin for Prevention of Post Stroke Delirium
Lead Sponsor:
University Hospital Tuebingen
Conditions:
Post Stroke Delirium
Eligibility:
All Genders
55+ years
Phase:
PHASE2
PHASE3
Brief Summary
Post stroke delirium is prevalent in 10-30% of all stroke patients. We aimed to investigate wether Melatonin 2mg may prevent post stroke delirium.
Eligibility Criteria
Inclusion
- all patients with stroke, TIA or ICH admitted to our stroke unit or intemdiate care unit
- Stroke / ICH /TIA onset \<= 48h
Exclusion
- RASS \<=4
- severe dementia, psychosis or depression
Key Trial Info
Start Date :
July 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04122599
Start Date
July 1 2017
End Date
December 31 2019
Last Update
October 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik für Neurologie
Tübingen, Baden-Wurttemberg, Germany, 72076